» Authors » K-U Kohrmann

K-U Kohrmann

Explore the profile of K-U Kohrmann including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 211
Followers 0
Related Specialty
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ganzer R, Franiel T, Kollermann J, Kuru T, Baumunk D, Blana A, et al.
Urologe A . 2017 Sep; 56(10):1335-1346. PMID: 28856386
The target of focal therapy (FT) in prostate cancer (PC) is partial treatment of the prostate aiming at preserving surrounding anatomical structures. The intention is to minimize typical side effects...
2.
Franz T, von Hardenberg J, Blana A, Cash H, Baumunk D, Salomon G, et al.
Urologe A . 2016 Nov; 56(2):208-216. PMID: 27844131
Background: Several systems for MRI/TRUS fusion-guided biopsy of the prostate are commercially available. Many studies have shown superiority of fusion systems for tumor detection and diagnostic quality compared to random...
3.
Volkmer B, Petschl S, Chaussy C, Kohrmann K, Haupt G, Jocham D
Urologe A . 2009 Jul; 48(10):1214-21. PMID: 19585097
Urolithiasis is the disease that leads to the largest number of inpatient treatments in urologic clinics in Germany. It is very important to know the current rules of remuneration for...
4.
Hartmann M, Siener R, Krege S, Schmelz H, Dieckmann K, Heidenreich A, et al.
Urologe A . 2009 Feb; 48(5):523-8. PMID: 19183929
Objective: As 30% of non-seminomas in clinical stage I will progress during active surveillance, alternative adjuvant strategies of 2 cycles of bleomycin, etoposid, cisplatin (BEP) or nerve sparing retroperitoneal lymphadenectomy...
5.
Hesse A, Brandle E, Wilbert D, Kohrmann K, Alken P
Eur Urol . 2003 Dec; 44(6):709-13. PMID: 14644124
Objectives: In 1979, we conducted a representative study to determine the prevalence and incidence of urolithiasis in Germany. Significant progress in stone therapy and changes in nutritional and environmental factors...